In 1998, Dr. Czarnik’s group at Parke-Davis reported the first successful drug discovery effort in which RNA was the target. His group also conducted the first successful effort to discover small molecule drugs that work by binding to RNA. This has led to the creation of a new field of drug discovery, notably the focus of startup companies and scientific conferences.